Share

Insulet (NSDQ:PODD) said this week that it inked a deal with Samsung to develop an Omnipod insulin delivery system that would allow users to control their insulin pump therapy with a Galaxy smartphone.

If approved, the system would be the first of its kind, according to the Billerica, Mass.-based company.

Get the full story at our sister site, Drug Delivery Business News.




textadimage

On December 11-12,DeviceTalks West is taking over Orange County’s medtech industry with one of the most anticipated conferences of the winter, bringing you the best and brightest minds in the industry.

Keynote Speakers

Dr. Robert Greenberg, Executive Chairman, Alfred E. Mann Foundation

Gary Guthart, President and Chief Executive Officer, Intuitive Surgical

Reggie Groves, CEO, REVA Medical

REGISTER NOW

Use code KEYNOTE to save an additional 10%.



READ SOURCE

LEAVE A REPLY

Please enter your comment!
Please enter your name here